Albumin is the most abundant protein in plasma, which is biocompatible, non-toxic, metabolized without harmful substances in vivo, non-antigenic, easily purified and water-soluble, and can be administered by intravenous injection. Since albumin has a variety of drug binding sites, albumin nanoparticles can encapsulate various drugs, and its structural domain contains hydrophobic domains, which can better encapsulate hydrophobic drugs.
CD Formulation improves the optimization service of albumin nanoparticle drug delivery and helps customers to perfect their albumin-drug formulations. Our professional staff will develop a suitable customized solution for you, and combined with our quality assurance system, we believe that we will bring you satisfaction.
The modification of cell-specific ligands on the surface of nanoparticles can improve nanoparticle targeting, drug pharmacokinetics and tissue distribution, as well as prevent premature drug release, which can lead to drug toxicity and reduced efficacy. CD Formulation can perform modification services including: modification of cell-penetrating peptides, modification of endogenous substances, other substances and functionalized modifications.
CD Formulation can perform drug content analysis of prepared albumin-loaded drugs, including determination of encapsulation rate and drug loading, as well as testing of nanoparticle morphology, particle size and Zata potential.
Based on the data obtained from the tests, we provide formulation optimization services to help our customers to better develop and release their drugs.
CD Formulation provides integrated innovation solutions from strategy to implementation to help you increase opportunities and address challenges. Through our in-depth experience in many different industries, including consumer and technology, we bring innovative solutions and cross-industry best practices to drug development. If you have a requirement about our services, please contact us by phone or email, our colleagues will reply to you within three working days.